HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Gossamer Bio (NASDAQ:GOSS) and maintained a $10 price target, as stated by analyst Patrick Trucchio.
May 20, 2024 | 3:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Gossamer Bio and maintained a $10 price target, indicating continued confidence in the company's potential.
The reiteration of a Buy rating and maintenance of a $10 price target by a reputable analyst firm like HC Wainwright & Co. is likely to positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100